Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 28, 2007; 13(44): 5888-5901
Published online Nov 28, 2007. doi: 10.3748/wjg.v13.i44.5888
Published online Nov 28, 2007. doi: 10.3748/wjg.v13.i44.5888
Figure 1 Chemical structure of the three most important drugs used in colorectal chemotherapy: 5-FU, CPT11 and Oxaliplatin.
Figure 2 Metabolism and mechanism of action of 5-fluoruracil (5-FU).
The potential predictive markers for 5-FU response are in red-boxes.
Figure 3 Metabolism and mechanism of action of Irinotecan (CPT-11).
The potential predictive markers for CPT-11 response are in red-boxes.
Figure 4 Mechanisms of action for the epidermal growth factor receptor and VEGF.
Figure 5 Combination of predictive gene sets for different therapies used in CRC.
- Citation: Bandrés E, Zárate R, Ramirez N, Abajo A, Bitarte N, García-Foncillas J. Pharmacogenomics in colorectal cancer: The first step for individualized-therapy. World J Gastroenterol 2007; 13(44): 5888-5901
- URL: https://www.wjgnet.com/1007-9327/full/v13/i44/5888.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i44.5888